Showing results (681-690 of 720) with videos related to

Sort By:
Pageof 72
Nature|August 9, 2016
Defining CD8+ T cells that provide the proliferative burst after PD-1 therapySe Jin Im, Masao Hashimoto, Michael Y Gerner, et al.
Journal of Neuropathology and Experimental Neurology|March 14, 2001
Oligodendrogliomas: reproducibility and prognostic value of histologic diagnosis and gradingC Giannini, B W Scheithauer, A L Weaver, et al.
Nature Communications|September 6, 2023
Xanomeline displays concomitant orthosteric and allosteric binding modes at the M4 mAChRWessel A C Burger, Vi Pham, Ziva Vuckovic, et al.
American Journal of Medical Genetics. Part A|May 22, 2023
Recessive CHRM5 variant as a potential cause of neurogenic bladderSophia Schneider, Luca Schierbaum, Wessel A C Burger, et al.
British Journal of Cancer|March 19, 2025
CAR-NK cell therapy combined with checkpoint inhibition induces an NKT cell response in glioblastomaF Strassheimer, P Elleringmann, G Ludmirski, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 28, 2019
Crystal structure of the M5 muscarinic acetylcholine receptorZiva Vuckovic, Patrick R Gentry, Alice E Berizzi, et al.
Acta Neuropathologica|August 13, 2015
A clinicopathologic study of diencephalic pediatric low-grade gliomas with BRAF V600 mutationCheng-Ying Ho, Bret C Mobley, Heather Gordish-Dressman, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 20, 2008
Issues of diagnostic review in brain tumor studies: from the Brain Tumor Epidemiology ConsortiumFaith G Davis, Beatrice S Malmer, Ken Aldape, et al.
Cancer|August 10, 2005
The prognostic impact of histology and 1p/19q status in anaplastic oligodendroglial tumorsJ Matthew McDonald, Siew Ju See, Ivo W Tremont, et al.
Pageof 72